Espicom market intelligence, brought to you by Business Monitor InternationalOman Pharmaceuticals & Healthcare ReportOman's commendable public healthcare system and high-class tertiary and quaternary care hospitals will increase the uptake of medical tourism by GCC citizens. The Omani pharmaceutical market will continue to remain heavily reliant on imports due to the costly need to source raw ingredients for local manufacturing and lack of R&D backing. However, despite t he strict drug pricing system, we are likely to see more multinational companies penetrating the market and expanding volume sales, by addressing the increasing burden of non-communicable diseases in the country.Headline Expenditure Projections Pharmaceuticals : OMR151mn (US$391mn) in 2011 to OMR166mn in 2012; +9.9% in local currency terms and +11.3% in US dollar terms. Forecast revised upwards due to modi fications to historical figures. Healthcare: OMR742mn (US$1.93bn) in 2011 to OMR839mn (US$2.21bn) in 2012; +13.1% in local currency terms and +14.6% in US dollar terms. Forecast revised upwards due to modifications to historical figures . Medical devices: OMR40mn (US$105mn) in 2011 to OMR44mn (US$116mn) in 2012; +9.5% in local currency terms and +10.9% in US dollar terms. Forecast revised upwards due to modi fications to historical figures. Risk / Reward Rating: Risk-Reward Rating scores represent a country's pharmaceutical market attractiveness for investment, which includes weightings of risk and rewards analysis of the wider macroeconomic environment. Oman's consistent score of 50.2 out of 100 over the past three quarters places it above the MEA regional average of 44.2, indicating a favourable and stable environment for multinational investment. Oman also currently maintains its position as ninth out of 30 countries in the MEA matrix.Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Oman
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
Oman Pharmaceuticals & Healthcare Report
Oman's commendable public healthcare system and high-class tertiary and quaternary care hospitals will increase the uptake of
medical tourism by GCC citizens. The Omani pharmaceutical market will continue to remain heavily reliant on imports due to the
costly need to source raw ingredients for local manufacturing and lack of R&D backing. However, despite t he strict drug pricing
system, we are likely to see more multinational companies penetrating the market and expanding volume sales, by addressing the
increasing burden of non-communicable diseases in the country.
Headline Expenditure Projections
Pharmaceuticals : OMR151mn (US$391mn) in 2011 to OMR166mn in 2012; +9.9% in local currency terms and +11.3% in US dollar
terms. Forecast revised upwards due to modi fications to historical figures.
Healthcare: OMR742mn (US$1.93bn) in 2011 to OMR839mn (US$2.21bn) in 2012; +13.1% in local currency terms and +14.6% in
US dollar terms. Forecast revised upwards due to modifications to historical figures .
Medical devices: OMR40mn (US$105mn) in 2011 to OMR44mn (US$116mn) in 2012; +9.5% in local currency terms and +10.9% in
US dollar terms. Forecast revised upwards due to modi fications to historical figures.
Risk / Reward Rating: Risk-Reward Rating scores represent a country's pharmaceutical market attractiveness for investment, which
includes weightings of risk and rewards analysis of the wider macroeconomic environment. Oman's consistent score of 50.2 out of
100 over the past three quarters places it above the MEA regional average of 44.2, indicating a favourable and stable environment for
multinational investment. Oman also currently maintains its position as ninth out of 30 countries in the MEA matrix.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
SWOT Analysis 7
The Pharmaceutical Market: Oman (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Oman Pharmaceuticals And Healthcare Industry SWOT 7
Oman Political SWOT 8
Oman Economic SWOT 8
Oman Business Environment SWOT 9
Pharmaceutical Risk/Reward Ratings 10
Table: Middle East And Africa (MEA) Pharmaceutical Risk/Reward Ratings, Q113 10
Rewards 12
Risks 13
Oman ' Market Summary 15
Regulatory Regime 17
Regulatory Developments 18
Intellectual Property Regime 18
Table: IP Laws In Oman 19
Regional Harmonisation 19
Pricing And Reimbursement Regime 20
Recent Pricing And Reimbursement Developments 21
Free Trade Agreements 22
Industry Developments 24
Epidemiology 24
Communicable Diseases 25
Non-Communicable Diseases 26
Public Health Developments 27
Healthcare Sector 28
Table: Number Of Health Centres In Oman By Region 28
Table: Number And Type Of Health Institutions In Oman 29
Healthcare System Developments 29
Table: Healthcare Reform Targets 31
Private Healthcare Sector 31
Private Healthcare Developments 32
Healthcare Funding 33
Healthcare Insurance 33
Telemedicine 34
Medical Tourism 34
Research And Biotechnology 36
Clinical Trials 37
Medical Devices 38
Industry Forecast Scenario 39
Overall Market Forecast 39
Table: Oman Pharmaceutical Sales, Historical Data And Forecasts, 2007-2017 40
Key Growth Factors ' Industry 41
Table: Oman Healthcare Expenditure Trends, Historical Data and Forecasts 42
Table: Oman Government Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 42
Table: Oman Private Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 43
Key Growth Factors ' Macroeconomic 44
Table: Oman ' GDP By Expenditure, Current Prices Breakdown, 2008-2016 48
Prescription Drug Market Forecast 49
Table: Oman Prescription Drug Market Indicators, Historical Data And Forecasts, 2009-2017 50
Patented Drug Market Forecast 51
The Pharmaceutical Market: Oman (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table: Oman Patented Drug Market Indicators, Historical Data and Forecasts 52
Generic Drug Market Forecast 53
Table: Oman Generics Drug Market Indicators, Historical Data And Forecasts, 2009-2017 54
OTC Medicine Market Forecast 55
Table: Oman Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017 56
Pharmaceutical Trade Forecast 57
Table: Oman Pharmaceutical Trade Data And Forecasts (US$mn), 2009-2017 58
Table: Oman Pharmaceutical Trade Data And Forecasts (OMRmn), 2009-2017 58
Medical Device Market Forecast 59
Table: Oman Medical Device Market Indicators, Historical Data and Forecasts, 2009-2017 60
Other Healthcare Data Forecasts 61
Key Risks To BMI's Forecasts 62
Competitive Landscape 63
Pharmaceutical Sector 63
Domestic Industry 63
Foreign Industry 64
Pharmaceutical Distribution 65
Company Profiles 66
Local Companies 66
Zynova/Oman Pharmaceutical Products Company (OPPC) 66
National Pharmaceutical Industries (NPI) 68
Multinational Companies 70
Novartis 70
GlaxoSmithKline 72
Sanofi 73
Johnson & Johnson 74
Demographic Outlook 75
Table: Population By Age Group, 1990-2020 ('000) 76
Table: Population By Age Group, 1990-2020 (% of total) 76
Table: Key Population Ratios, 1990-2020 77
Table: Rural/Urban Population Split, 1990-2020 77
Glossary 79
BMI Methodology 81
How We Generate Our Pharmaceutical Industry Forecasts 81
Risk/Reward Ratings Methodology 82
Ratings Overview 82
Table: Pharmaceutical Business Environment Indicators 83
Weighting 84
Table: Weighting Of Components 84
Sources 84
The Pharmaceutical Market: Oman (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Oman
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Oman (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Oman (From Slideshare) Page 5/5